MO-TC: TB and HIV
- National TB-HIV Collaborative Framework
- District AIDS Prevention and Control Units [DAPCU]
- Intensified TB Case Finding [ICF] in HIV testing Settings
- HIV testing of individuals with presumed or confirmed TB
- ART For TB-HIV Patients
- Immune Reconstitution Inflammatory Syndrome [IRIS]
- Co-trimoxazole prophylactic therapy in persons with HIV and TB coinfection
- Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV]
- Linkage to TB-HIV services in the private sector
- Prevention of TB in facilities caring for HIV-infected persons
MO-TC: Monitoring of Treatment
- Monitoring indicator for TB Treatment outcome
- Monitoring indicators related to DR-TB Treatment
- NTEP Performance Indicator - Treatment Success Rate
- NTEP Performance Indicator – Percentage Of Multidrug-resistant [MDR]/ Rifampicin-resistant [RR] Patients Initiated on Treatment Out of Totally Diagnosed
- RCA for low performance in in Percentage Treatment initiation of RR/MDR-TB Cases
- DR-TB Treatment Register
- Prescription Register
- Follow-Up Register
- DRTB Follow Up Register
MO-TC: Adherence Management
- TB Treatment Adherence
- Importance of Treatment adherence
- Recording and Monitoring Adherence
- Digital Adherence Monitoring Technologies
- Directly Observed Treatment [DOT]
- Recording Adherence in Treatment card
- Recording manual doses in Ni-kshay
- Recording missed doses in Ni-kshay
- Recording Adherence using TB Arogya Sathi Application
- 99 DOTS- Features and Benefits
- 99 DOTS- Envelopes
- 99 DOTS- Envelope Dispensing Process
- 99 DOTS- Initiating adherence monitoring of the patient
- 99 DOTS- Self Reporting Adherence
- Medication Event Reminder Monitor [MERM] Boxes
- Monitoring of Adherence by NTEP Staff
- Monitoring of Adherence by Pateint/TS
- Adherence Summary Dashboard
- Management of Patients with Treatment Interruptions
- Adherence Register
- Switch Technology Register
- Patient Adherence Dashboard
MO-TC: Isoniazid [H] Mono/Poly DR-TB Regimen
- Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
- EVIDENCE FOR ISONIAZID[H] MONO/POLY DR-TB REGIMEN
- Eligibility Criteria for H Mono/poly DR-TB Regimen
- Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
- Replacement Sequence in the H Mono/Poly DR-TB
- Follow up sputum examination for Isoniazid [H] Mono/Poly DR-TB Regimen